Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Higher HbA1c Following Younger Age of Transfer From Pediatric to Adult Type 1 Diabetes Services: Data From the Australasian Diabetes Data Network (ADDN) Registry.

Diabetes care·2026

Same author

Perspective: Improving social connection and inclusion through equitable digital health solutions.

NPJ digital medicine·2025

Same author

Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.

Diabetologia·2025

Same author

Citizen science informed online platform to increase social connection, physical health and mental wellbeing in people with disability and carers: <i>ConnectUp</i> project protocol.

Disability and rehabilitation. Assistive technology·2025

Same author

The Patient-Oriented Neuroendocrine Tumor Registry for Australia.

Studies in health technology and informatics·2025

Same author

GTMALoc: prediction of miRNA subcellular localization based on graph transformer and multi-head attention mechanism.

Frontiers in genetics·2025

Same journal

A GenAI Pipeline for Violinist Kinematic Data Management.

Studies in health technology and informatics·2026

Same journal

AMAL-For-Qatar: A Comprehensive AI Ecosystem for Fetal Ultrasound Analysis - Project Overview and Achievements.

Studies in health technology and informatics·2026

Same journal

Longitudinal Treatment-Aware Multimodal AI for Dermatology: A Scoping Review.

Studies in health technology and informatics·2026

Same journal

Predicting Postpartum Depression Using Imbalance-Aware Machine Learning.

Studies in health technology and informatics·2026

Same journal

Validation of Deep-Learning Models for Autosegmentation of Brain Metastases.

Studies in health technology and informatics·2026

Same journal

Delay-Dependent Gating in Modular RNNs.

Studies in health technology and informatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Enabling secure, distributed collaborations for adrenal tumor research.

Anthony Stell¹, Richard Sinnott, Jipu Jiang

¹National e-Science Centre, University of Glasgow, UK.

Studies in Health Technology and Informatics

|June 15, 2010

Summary

This summary is machine-generated.

Securely integrating rare adrenal tumor data across Europe is crucial for research. A new VANGUARD technology prototype ensures patient privacy through layered encryption and data separation, enabling collaborative e-Health strategies.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Experiment Videos

Last Updated: Jun 12, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Area of Science:

Health Informatics
Bioinformatics
Oncology

Background:

e-Health strategies require secure integration of distributed datasets.
Patient privacy and data security are paramount in healthcare data transmission.
The European Network for the Study of Adrenal Tumors (ENSAT) faces challenges in linking clinical and genomic data across institutions.

Purpose of the Study:

To describe a prototype solution for secure data integration in the ENSAT network.
To demonstrate patient-privacy protecting capabilities for linked clinical and genomic data.
To support collaborative research on rare adrenal tumors.

Main Methods:

Development of a security-oriented tailored portal.
Implementation of a layered encryption-driven linkage technology (VANGUARD).
Ensuring clear separation of clinical and genomic datasets.
Supporting rigorous patient-identity protecting access control across organizational boundaries.

Main Results:

A functional prototype supporting the ENSAT network has been implemented.
The VANGUARD technology provides patient-privacy protecting capabilities for linked data.
The solution facilitates secure access and comparison of distributed clinical and genomic data.

Conclusions:

The VANGUARD prototype offers a viable solution for secure e-Health data integration in multi-institutional research networks.
This approach addresses critical information governance, ethics, and privacy concerns.
The technology enables enhanced research collaboration for rare diseases like adrenal tumors.